AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Strategy Training for Optimizing Attention for Individuals With Spatial Neglect

RecruitingNAAges 18 Years - anyAllUniversity of Pittsburgh
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

It is common for individuals after stroke to have a cognitive perceptual impairment called unilateral spatial neglect (neglect). Individuals with neglect have difficulty paying attention to one side of their body or one side of the environment and therefore experience difficulty performing daily activities. There are a lack of effective treatments for neglect and new interventions are needed to help reduce disability for these individuals. Metacognitive strategy training (strategy training) is an intervention that has the potential to reduce neglect-related disability and improve individuals' attention and awareness of their neglect. This study seeks to examine the effects of strategy training on neglect, self-awareness, and disability, specifically for individuals who are living in the community after their stroke.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * had a stroke * presence of neglect as determined by score of \<18 or 2 or more collisions on the Virtual Reality Lateralized Attention Test (VRLAT); score below established cutoff for neglect on one of the six subtests of the Behavioral Inattention Test (BIT); OR reported signs/symptoms of neglect * โ‰ฅ18 years old * lives within 30 miles of the University of Pittsburgh in a community dwelling. Exclusion Criteria: * Boston Diagnostic Aphasia Examination (BDAE) Severity Scale score of 0 * dementia per medical record * active major depressive disorder per medical record * not willing to be videotaped * subject is currently receiving rehabilitation therapy as part of their usual care
๐Ÿ’Š

What it tests

  • Strategy Training
  • Attention Control
๐Ÿ“

Where

1 site
University of Pittsburgh
Pittsburgh, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy